{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:46Z","timestamp":1793212126634,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Saponins represent a promising class of vaccine adjuvant. Together with the TLR4-ligand MPL, QS-21 is part of the Adjuvant System AS01, a key component of the malaria and zoster candidate vaccines that display demonstrated clinical efficacy. However, the mechanism of action of QS-21 in this liposomal formulation is poorly understood. Upon intra-muscular immunisation, we observed that QS-21 rapidly accumulated in CD169<jats:sup>+<\/jats:sup> resident macrophages of the draining lymph node where it elicited a local innate immune response. Depletion of these cells abrogated QS-21-mediated innate cell recruitment to the lymph node, dendritic cell (DC) phenotypic maturation as well as the adjuvant effect on T-cell and antibody responses to co-administered antigens. DCs rather than lymph node-resident macrophages were directly involved in T-cell priming by QS-21, as revealed by the decrease in antigen-specific T-cell response in <jats:italic>Batf3<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. Further analysis showed that the adjuvant effect of QS-21 depended on the integration of Caspase-1 and MyD88 pathways, at least in part through the local release of HMGB1. Taken together, this work unravels the key role of lymph node sentinel macrophage in controlling the adjuvant effect of a molecule proven to improve vaccine response in humans.<\/jats:p>","DOI":"10.1038\/srep39475","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T11:03:19Z","timestamp":1482231799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01"],"prefix":"10.1038","volume":"6","author":[{"given":"Sophie","family":"Detienne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Welsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Delhaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurye","family":"Van Maele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Swertvaegher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Detavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelatif","family":"Elouahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Goriely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud M.","family":"Didierlaurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"BFsrep39475_CR1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","volume":"19","author":"SG Reed","year":"2013","unstructured":"Reed, S. G., Orr, M. T. & Fox, C. B. Key roles of adjuvants in modern vaccines. Nat. Med. 19, 1597\u2013608 (2013).","journal-title":"Nat. Med."},{"key":"BFsrep39475_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal, H. et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372, 2087\u201396 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep39475_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"SCTP RTS","year":"2015","unstructured":"RTS, S. C. T. P. Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015).","journal-title":"Lancet"},{"key":"BFsrep39475_CR4","unstructured":"White, M. T. et al. Immunogenicity of the RTS, S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: Secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect. Dis. 15 (2015)."},{"key":"BFsrep39475_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/erv.11.29","volume":"10","author":"N Gar\u00e7on","year":"2011","unstructured":"Gar\u00e7on, N. & Van Mechelen, M. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems. Expert Rev. Vaccines 10, 471\u201386 (2011).","journal-title":"Expert Rev. Vaccines"},{"key":"BFsrep39475_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","volume":"193","author":"AM Didierlaurent","year":"2014","unstructured":"Didierlaurent, A. M. et al. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells. J. Immunol. 193, 1920\u201330 (2014).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","volume":"27","author":"H-X Sun","year":"2009","unstructured":"Sun, H.-X., Xie, Y. & Ye, Y.-P. Advances in saponin-based adjuvants. Vaccine 27, 1787\u20131796 (2009).","journal-title":"Vaccine"},{"key":"BFsrep39475_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","volume":"146","author":"CR Kensil","year":"1991","unstructured":"Kensil, C. R., Patel, U., Lennick, M. & Marciani, D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146, 431\u20137 (1991).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1586\/14760584.6.5.723","volume":"6","author":"N Gar\u00e7on","year":"2007","unstructured":"Gar\u00e7on, N., Chomez, P. & Van Mechelen, M. GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Rev. Vaccines 6, 723\u2013739 (2007).","journal-title":"Expert Rev. Vaccines"},{"key":"BFsrep39475_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1517\/13543784.7.9.1475","volume":"7","author":"CR Kensil","year":"1998","unstructured":"Kensil, C. R. & Kammer, R. QS-21: a water-soluble triterpene glycoside adjuvant. Expert Opin. Investig. Drugs 7, 1475\u201382 (1998).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFsrep39475_CR11","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.148.8.2357","volume":"148","author":"MJ Newman","year":"1992","unstructured":"Newman, M. J. et al. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J. Immunol. 148, 2357\u201362 (1992).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.4049\/jimmunol.182.3.1253","volume":"182","author":"M Schnurr","year":"2009","unstructured":"Schnurr, M. et al. ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. J. Immunol. 182, 1253\u20139 (2009).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR13","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/S0264-410X(02)00209-8","volume":"20","author":"G Liu","year":"2002","unstructured":"Liu, G., Anderson, C., Scaltreto, H., Barbon, J. & Kensil, C. R. QS-21 structure\/function studies: effect of acylation on adjuvant activity. Vaccine 20, 2808\u201315 (2002).","journal-title":"Vaccine"},{"key":"BFsrep39475_CR14","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/S0264-410X(00)00415-1","volume":"19","author":"TG Evans","year":"2001","unstructured":"Evans, T. G. et al. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. Vaccine 19, 2080\u201391 (2001).","journal-title":"Vaccine"},{"key":"BFsrep39475_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1586\/erv.11.18","volume":"10","author":"G Ragupathi","year":"2011","unstructured":"Ragupathi, G., Gardner, J. R., Livingston, P. O. & Gin, D. Y. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. Expert Rev. Vaccines 10, 463\u201370 (2011).","journal-title":"Expert Rev. Vaccines"},{"key":"BFsrep39475_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","volume":"181","author":"H Li","year":"2008","unstructured":"Li, H., Willingham, S. B., Ting, J. P.-Y. & Re, F. Cutting edge: inflammasome activation by alum and alum\u2019s adjuvant effect are mediated by NLRP3. J. Immunol. 181, 17\u201321 (2008).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR17","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1074\/jbc.M115.683011","volume":"291","author":"R Marty-Roix","year":"2016","unstructured":"Marty-Roix, R. et al. Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants. J. Biol. Chem. 291, 1123\u201336 (2016).","journal-title":"J. Biol. Chem."},{"key":"BFsrep39475_CR18","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.4049\/jimmunol.1302011","volume":"192","author":"NS Wilson","year":"2014","unstructured":"Wilson, N. S. et al. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant. J. Immunol. 192, 3259\u201368 (2014).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N. S. et al. Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"BFsrep39475_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/nar\/gks1147","volume":"41","author":"K Breuer","year":"2013","unstructured":"Breuer, K. et al. InnateDB: Systems biology of innate immunity and beyond - Recent updates and continuing curation. Nucleic Acids Res. 41, 1228\u20131233 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep39475_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-cellbio-100913-013254","volume":"30","author":"H Qi","year":"2014","unstructured":"Qi, H., Kastenm\u00fcller, W. & Germain, R. N. Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue. Annu. Rev. Cell Dev. Biol. 30, 141\u201367 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFsrep39475_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1126\/science.aaa1300","volume":"347","author":"M Gaya","year":"2015","unstructured":"Gaya, M. et al. Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection. Sci. 347, 667\u2013672 (2015).","journal-title":"Sci."},{"key":"BFsrep39475_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm.4016","volume":"22","author":"P Sagoo","year":"2016","unstructured":"Sagoo, P. et al. In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity. Nat. Med. 22, 64\u201371 (2016).","journal-title":"Nat. Med."},{"key":"BFsrep39475_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06287","volume":"450","author":"T Junt","year":"2007","unstructured":"Junt, T. et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450, 110\u20134 (2007).","journal-title":"Nature"},{"key":"BFsrep39475_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","volume":"27","author":"YR Carrasco","year":"2007","unstructured":"Carrasco, Y. R. & Batista, F. D. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27, 160\u201371 (2007).","journal-title":"Immunity"},{"key":"BFsrep39475_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.cell.2012.07.021","volume":"150","author":"W Kastenm\u00fcller","year":"2012","unstructured":"Kastenm\u00fcller, W., Torabi-Parizi, P., Subramanian, N., L\u00e4mmermann, T. & Germain, R. N. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150, 1235\u201348 (2012).","journal-title":"Cell"},{"key":"BFsrep39475_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jlb.47.3.251","volume":"47","author":"FG Delemarre","year":"1990","unstructured":"Delemarre, F. G., Kors, N., Kraal, G. & van Rooijen, N. Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. J. Leukoc. Biol. 47, 251\u20137 (1990).","journal-title":"J. Leukoc. Biol."},{"key":"BFsrep39475_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843\u2013850 (2007).","journal-title":"Nat. Med."},{"key":"BFsrep39475_CR29","first-page":"1","volume":"7","author":"M Larsen","year":"2012","unstructured":"Larsen, M. et al. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS One 7, 1\u201310 (2012).","journal-title":"PLoS One"},{"key":"BFsrep39475_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.immuni.2010.12.011","volume":"34","author":"K Asano","year":"2011","unstructured":"Asano, K. et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34, 85\u201395 (2011).","journal-title":"Immunity"},{"key":"BFsrep39475_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000337007","volume":"4","author":"EE Gray","year":"2012","unstructured":"Gray, E. E. & Cyster, J. G. Lymph node macrophages. Journal of Innate Immunity 4, 424\u2013436 (2012).","journal-title":"Journal of Innate Immunity"},{"key":"BFsrep39475_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity. Science (80\u2212). 322, 1097\u20131100 (2008).","journal-title":"Science (80\u2212)."},{"key":"BFsrep39475_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.20091627","volume":"207","author":"BT Edelson","year":"2010","unstructured":"Edelson, B. T. et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207, 823\u201336 (2010).","journal-title":"J. Exp. Med."},{"key":"BFsrep39475_CR34","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.4049\/jimmunol.175.11.7611","volume":"175","author":"JM Kahlenberg","year":"2005","unstructured":"Kahlenberg, J. M., Lundberg, K. C., Kertesy, S. B., Qu, Y. & Dubyak, G. R. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J. Immunol. 175, 7611\u20137622 (2005).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR35","doi-asserted-by":"publisher","first-page":"821043","DOI":"10.1155\/2014\/821043","volume":"2014","author":"B Sangiuliano","year":"2014","unstructured":"Sangiuliano, B., P\u00e9rez, N. M., Moreira, D. F. & Beliz\u00e1rio, J. E. Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control. Mediators Inflamm. 2014, 821043 (2014).","journal-title":"Mediators Inflamm."},{"key":"BFsrep39475_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang, H. et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J. Exp. Med. 212, 5\u201314 (2015).","journal-title":"J. Exp. Med."},{"key":"BFsrep39475_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2007.02.011","volume":"26","author":"Ka Pape","year":"2007","unstructured":"Pape, K. a., Catron, D. M., Itano, A. a. & Jenkins, M. K. The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles. Immunity 26, 491\u2013502 (2007).","journal-title":"Immunity"},{"key":"BFsrep39475_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0171-2985(11)80663-7","volume":"182","author":"RE Mebius","year":"1991","unstructured":"Mebius, R. E., Bauer, J., Twisk, A. J., Brev\u00e9, J. & Kraal, G. The functional activity of high endothelial venules: a role for the subcapsular sinus macrophages in the lymph node. Immunobiology 182, 277\u201391 (1991).","journal-title":"Immunobiology"},{"key":"BFsrep39475_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2005.11.011","volume":"24","author":"LS Miller","year":"2006","unstructured":"Miller, L. S. et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24, 79\u201391 (2006).","journal-title":"Immunity"},{"key":"BFsrep39475_CR40","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.4049\/jimmunol.179.10.6933","volume":"179","author":"LS Miller","year":"2007","unstructured":"Miller, L. S. et al. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 179, 6933\u20136942 (2007).","journal-title":"J. Immunol."},{"key":"BFsrep39475_CR41","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/eji.200940039","volume":"40","author":"R Spreafico","year":"2010","unstructured":"Spreafico, R., Ricciardi-Castagnoli, P. & Mortellaro, A. The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants. Eur. J. Immunol. 40, 638\u201342 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFsrep39475_CR42","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1038\/cddis.2012.86","volume":"3","author":"a Denes","year":"2012","unstructured":"Denes, a., Lopez-Castejon, G. & Brough, D. Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis. 3, e338 (2012).","journal-title":"Cell Death Dis."},{"key":"BFsrep39475_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09737","volume":"470","author":"SP Kasturi","year":"2011","unstructured":"Kasturi, S. P. et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470, 543\u20137 (2011).","journal-title":"Nature"},{"key":"BFsrep39475_CR44","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1182\/blood-2005-06-2416","volume":"107","author":"S Goriely","year":"2006","unstructured":"Goriely, S. et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 107, 1078\u20131084 (2006).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39475","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:02:37Z","timestamp":1672902157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep39475"],"URL":"https:\/\/doi.org\/10.1038\/srep39475","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]},"assertion":[{"value":"9 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have declared the following interests. C.C., S.W., M.C., A.E., A.M.D. are employees of the GSK group of companies. S.W., A.E. and A.M.D. own GSK. stocks. The other authors report no financial conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39475"}}